Comerica Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,433
| Closed | -$265K | – | 460 |
|
|
2023
Q2 | $265K | Sell |
3,433
-2,280
| -40% | -$182K | 0.02% | 403 |
|
|
2023
Q1 | $474K | Sell |
5,713
-5,135
| -47% | -$425K | 0.03% | 304 |
|
|
2022
Q4 | $931K | Buy |
10,848
+3,387
| +45% | +$268K | 0.07% | 245 |
|
|
2022
Q3 | $460K | Buy |
7,461
+1,484
| +25% | +$93.6K | 0.04% | 284 |
|
|
2022
Q2 | $369K | Buy |
5,977
+963
| +19% | +$59.6K | 0.03% | 343 |
|
|
2022
Q1 | $298K | Buy |
5,014
+594
| +13% | +$38K | 0.02% | 404 |
|
|
2021
Q4 | $321K | Sell |
4,420
-1,829
| -29% | -$126K | 0.02% | 408 |
|
|
2021
Q3 | $436K | Buy |
6,249
+62
| +1% | +$4.36K | 0.03% | 335 |
|
|
2021
Q2 | $426K | Sell |
6,187
-1,559
| -20% | -$104K | 0.03% | 336 |
|
|
2021
Q1 | $501K | Sell |
7,746
-2,121
| -21% | -$137K | 0.04% | 317 |
|
|
2020
Q4 | $575K | Sell |
9,867
-2,823
| -22% | -$170K | 0.05% | 277 |
|
|
2020
Q3 | $802K | Buy |
12,690
+1,609
| +15% | +$112K | 0.07% | 211 |
|
|
2020
Q2 | $853K | Sell |
11,081
-5,390
| -33% | -$413K | 0.08% | 199 |
|
|
2020
Q1 | $1.23M | Sell |
16,471
-233
| -1% | -$16.1K | 0.14% | 141 |
|
|
2019
Q4 | $1.08M | Buy |
16,704
+536
| +3% | +$34.9K | 0.1% | 186 |
|
|
2019
Q3 | $1.02M | Buy |
16,168
+8,506
| +111% | +$556K | 0.11% | 184 |
|
|
2019
Q2 | $518K | Sell |
7,662
-29,435
| -79% | -$1.94M | 0.06% | 267 |
|
|
2019
Q1 | $2.41M | Sell |
37,097
-4,139
| -10% | -$275K | 0.27% | 91 |
|
|
2018
Q4 | $2.58M | Sell |
41,236
-6,444
| -14% | -$450K | 0.34% | 75 |
|
|
2018
Q3 | $3.68M | Buy |
47,680
+12,220
| +34% | +$923K | 0.43% | 64 |
|
|
2018
Q2 | $2.51M | Buy |
35,460
+42
| +0.1% | +$2.97K | 0.3% | 101 |
|
|
2018
Q1 | $2.67M | Sell |
35,418
-1,643
| -4% | -$131K | 0.33% | 87 |
|
|
2017
Q4 | $2.65M | Sell |
37,061
-4,932
| -12% | -$375K | 0.33% | 89 |
|
|
2017
Q3 | $3.4M | Buy |
41,993
+38,035
| +961% | +$2.91M | 0.47% | 57 |
|
|
2017
Q2 | $280K | Sell |
3,958
-3,074
| -44% | -$205K | 0.04% | 329 |
|
|
2017
Q1 | $478K | Sell |
7,032
-3,623
| -34% | -$255K | 0.08% | 256 |
|
|
2016
Q4 | $1M | Buy |
10,655
+5,353
| +101% | +$398K | 0.25% | 102 |
|
|
2016
Q3 | $419K | Sell |
5,302
-1,588
| -23% | -$129K | 0.08% | 232 |
|
|
2016
Q2 | $575K | Sell |
6,890
-4,184
| -38% | -$371K | 0.12% | 194 |
|
|
2016
Q1 | $1.02M | Sell |
11,074
-344
| -3% | -$31K | 0.24% | 116 |
|
|
2015
Q4 | $1.16M | Sell |
11,418
-3,304
| -22% | -$344K | 0.29% | 95 |
|
|
2015
Q3 | $1.45M | Sell |
14,722
-11,508
| -44% | -$1.28M | 0.39% | 84 |
|
|
2015
Q2 | $3.07M | Buy |
26,230
+2,149
| +9% | +$235K | 0.76% | 22 |
|
|
2015
Q1 | $2.36M | Buy |
24,081
+13,426
| +126% | +$1.36M | 0.61% | 64 |
|
|
2014
Q4 | $1M | Buy |
10,655
+3,346
| +46% | +$346K | 0.31% | 86 |
|
|
2014
Q3 | $778K | Buy |
+7,309
| New | +$716K | 0.26% | 104 |
|
Other funds holding GILD
Comerica Securities's GILD Position: Q3 2023 in Review
Comerica Securities sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 3,433 shares — an estimated $265K sold.
Comerica Securities first reported a position in GILD in Q3 2014 and held it in 36 quarters. The position peaked at $3.68M in Q3 2018. 1,683 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Comerica Securities reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
- Comerica Securities sold 3,433 Gilead Sciences shares in Q3 2023, an estimated $265K.
- Comerica Securities first reported a position in Gilead Sciences in Q3 2014 and held it in 36 quarters.
- Comerica Securities's Gilead Sciences position peaked at $3.68M in Q3 2018.
- 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.